Live tape
Top 8, mentions 7d12,486SPCX2,580 mentions▲ +0.08GOOGL2,025 mentions▲ +0.02META1,944 mentions▲ +0.04TSLA1,881 mentions▲ +0.05QQQ1,068 mentions▲ +0.05NFLX1,033 mentions▲ +0.03NVDA1,000 mentions▲ +0.07AMZN955 mentions▲ +0.06

Equity · Healthcare

ANGO

NASDAQ

AngioDynamics (ANGO)

$12.37 +3.04% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 23, 2026
Price · Chart
64 sessions
$18 $10 27 Jul 23 Oct

The line runs $13.64 on 27 July through $12.37 on 23 October, on a scale from $10 to $18. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView TradingView chart · our licensed closes: 64 sessions, 27 Jul – 23 Oct 2026
Market cap $520.0M
52-week range $9.70 – $16.08
Avg volume 65.9K

as of Oct 23, 2026

AngioDynamics (ANGO) insider trades

SEC Form 4 · last 90 days · newest reported trade 30 Jul 2026

In the 90 days to 25 Oct 2026, AngioDynamics insiders reported 1 open-market sale and no purchases (SEC Form 4); none has bought on the open market since 21 Oct 2025.

Open-market buys 0
Open-market sells 1
Net sold $344K
Non-trade filings 0
Date Insider Type Shares Value
30 Jul 2026 Nighan Warren JR SVP Quality and Regulatory Sell 23,370 $344K

AngioDynamics (ANGO) reported financials

SEC EDGAR XBRL SEC EDGAR

AngioDynamics reported revenue of $320.2M for the fiscal year ended 31 May 2026. Net income over the same period was −$36.7M.

Figure Reported Period
Revenue $320.2M 31 May 2026 fiscal year
Net income −$36.7M 31 May 2026 fiscal year
Diluted EPS −$0.88 31 May 2026 fiscal year
Total assets $241.9M 31 Aug 2026 at period end
Total equity $164.0M 31 Aug 2026 at period end

AngioDynamics (ANGO) earnings

SEC EDGAR

AngioDynamics last reported earnings on 31 Aug 2026 for Q1 2027, with EPS of −$0.17; no next date is announced in SEC filings yet.

Date Period EPS Revenue
31 Aug 2026 Q1 2027 −$0.17 —
31 May 2026 FY 2026 −$0.88 —
28 Feb 2026 Q3 2026 −$0.19 —
30 Nov 2025 Q2 2026 −$0.15 —
31 Aug 2025 Q1 2026 −$0.26 —
31 May 2025 FY 2025 −$0.83 —
28 Feb 2025 Q3 2025 −$0.11 —
30 Nov 2024 Q2 2025 −$0.26 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

AngioDynamics (ANGO) institutional holders (13F)

SEC Form 13F SEC EDGAR

9 of the 45 institutional funds we track reported a AngioDynamics position for the quarter ended 30 Jun 2026 — a combined $77.3M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Point72 Asset Management Held (±25%) −3.7% shares 3,062,517 $39.8M
Millennium Management Held (±25%) +21.5% shares 783,125 $10.2M
Renaissance Technologies Held (±25%) −8.6% shares 733,883 $9.5M
AQR Capital Management Added +134.2% shares 589,157 $7.7M
Marshall Wace Held (±25%) −13.4% shares 420,378 $5.5M
Two Sigma Investments Added +32.9% shares 306,260 $4.0M
Tudor Investment Corp Trimmed −58.0% shares 19,453 $253K
Citadel Advisors Trimmed −74.2% shares 12,484 $162K
Balyasny Asset Management New position 12,125 $158K

Congressional trades in AngioDynamics (ANGO)

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in AngioDynamics is a sale by Debbie Wasserman Schultz (house, FL), dated 16 Jul 2025.

Date Member Type Amount
16 Jul 2025 filed 25 Jul 2025 Debbie Wasserman Schultz house · Democrat–FL Sale $1K–$15K
27 Jun 2025 filed 25 Jul 2025 Debbie Wasserman Schultz house · Democrat–FL Purchase $1K–$15K

AngioDynamics (ANGO): frequently asked questions

From live data

Have AngioDynamics insiders bought or sold shares recently?

In the 90 days to 25 Oct 2026, AngioDynamics insiders reported 1 open-market sale and no purchases (SEC Form 4); none has bought on the open market since 21 Oct 2025.

How many institutions hold AngioDynamics?

9 of the 45 institutional funds we track reported a AngioDynamics position for the quarter ended 30 Jun 2026, per SEC Form 13F filings.

When did AngioDynamics last report earnings?

AngioDynamics last reported earnings on 31 Aug 2026 for Q1 2027, with EPS of −$0.17; no next date is announced in SEC filings yet.

What exchange is AngioDynamics listed on?

AngioDynamics trades on NASDAQ under the ticker ANGO.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 31 Aug 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. House disclosuresU.S. House of Representatives financial disclosures
  6. SEC EDGARValuation computed from SEC EDGAR filings